NAGLAZYME (Galsulfage) Logo

If you have any questions or comments about NAGLAZYME.com, feel free to use this page to e-mail us or contact BioMarin Patient and Physician Support (BPPS) at 1-866-906-6100. This site is a work in progress, and we are committed to making it as usable, informative, and helpful as possible. Any suggestions you have would be greatly appreciated.


(* Required field)

E-mail address*

My comment/question is about*

Please provide your comments/suggestions* (Maximum limit 1,000 characters)

IMPORTANT SAFETY INFORMATION

NAGLAZYME^® is indicated for patients with Mucopolysaccharidosis VI (MPS VI). NAGLAZYME^® has been shown to improve walking and stair-climbing capacity.

The most common adverse events observed in clinical trials in patients treated with NAGLAZYME^® were headache, fever, joint pain, vomiting, upper respiratory infections, abdominal pain, diarrhea, ear pain, cough, and ear infections. Severe reactions included swollen blood vessels, low blood pressure, difficulty breathing, respiratory distress, stopping breathing, and hives. The most common symptoms of infusion reactions included fever, chills/shakes, headache, rash and mild to moderate hives. Nausea, vomiting, elevated blood pressure, chest pain, abdominal pain, malaise, and joint pain were also reported.

Please see full prescribing information (PDF 440KB)

Region:

Text Size

NAGLAZYME (Galsulfage) Logo

Contact Us

IMPORTANT SAFETY INFORMATION